том 240 страницы 489-503

Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives

Тип публикацииJournal Article
Дата публикации2016-10-01
scimago Q1
wos Q1
БС1
SJR2.47
CiteScore19.4
Impact factor11.5
ISSN01683659, 18734995
Pharmaceutical Science
Краткое описание
Nanomedicine of synergistic drug combinations has shown increasing significance in cancer therapy due to its promise in providing superior therapeutic benefits to the current drug combination therapy used in clinical practice. In this article, we will examine the rationale, principles, and advantages of applying nanocarriers to improve anticancer drug combination therapy, review the use of nanocarriers for delivery of a variety of combinations of different classes of anticancer agents including small molecule drugs and biologics, and discuss the challenges and future perspectives of the nanocarrier-based combination therapy. The goal of this review is to provide better understanding of this increasingly important new paradigm of cancer treatment and key considerations for rational design of nanomedicine of synergistic drug combinations for cancer therapy.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

5
10
15
20
25
Journal of Controlled Release
22 публикации, 6.55%
International Journal of Nanomedicine
9 публикаций, 2.68%
International Journal of Molecular Sciences
8 публикаций, 2.38%
Pharmaceutics
7 публикаций, 2.08%
Journal of Drug Delivery Science and Technology
7 публикаций, 2.08%
ACS applied materials & interfaces
7 публикаций, 2.08%
Colloids and Surfaces B: Biointerfaces
6 публикаций, 1.79%
Biomaterials Science
6 публикаций, 1.79%
Nanomedicine
5 публикаций, 1.49%
Drug Delivery and Translational Research
5 публикаций, 1.49%
Advanced healthcare materials
5 публикаций, 1.49%
RSC Advances
5 публикаций, 1.49%
ACS Applied Bio Materials
4 публикации, 1.19%
Nanomaterials
4 публикации, 1.19%
Frontiers in Pharmacology
4 публикации, 1.19%
Biomedicine and Pharmacotherapy
4 публикации, 1.19%
International Journal of Biological Macromolecules
4 публикации, 1.19%
Acta Biomaterialia
4 публикации, 1.19%
Advanced Functional Materials
4 публикации, 1.19%
Nanoscale
4 публикации, 1.19%
Expert Opinion on Drug Delivery
4 публикации, 1.19%
Biomaterials
3 публикации, 0.89%
Advanced Drug Delivery Reviews
3 публикации, 0.89%
Journal of Materials Chemistry B
3 публикации, 0.89%
Nature Nanotechnology
2 публикации, 0.6%
Current Pharmaceutical Design
2 публикации, 0.6%
Assay and Drug Development Technologies
2 публикации, 0.6%
Therapeutic Delivery
2 публикации, 0.6%
Molecules
2 публикации, 0.6%
5
10
15
20
25

Издатели

20
40
60
80
100
120
Elsevier
113 публикаций, 33.63%
Springer Nature
43 публикации, 12.8%
Wiley
31 публикация, 9.23%
MDPI
30 публикаций, 8.93%
Taylor & Francis
27 публикаций, 8.04%
American Chemical Society (ACS)
25 публикаций, 7.44%
Royal Society of Chemistry (RSC)
22 публикации, 6.55%
Bentham Science Publishers Ltd.
10 публикаций, 2.98%
IOP Publishing
5 публикаций, 1.49%
Frontiers Media S.A.
4 публикации, 1.19%
SAGE
3 публикации, 0.89%
Pleiades Publishing
2 публикации, 0.6%
IGI Global
2 публикации, 0.6%
American Association for Cancer Research (AACR)
2 публикации, 0.6%
American Society for Pharmacology and Experimental Therapeutics
1 публикация, 0.3%
Mary Ann Liebert
1 публикация, 0.3%
World Scientific
1 публикация, 0.3%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 0.3%
National Autonomous University of Mexico, Faculty of Chemistry
1 публикация, 0.3%
Oxford University Press
1 публикация, 0.3%
De Gruyter Brill
1 публикация, 0.3%
PeerJ
1 публикация, 0.3%
Centre for Evaluation in Education and Science (CEON/CEES)
1 публикация, 0.3%
OAE Publishing Inc.
1 публикация, 0.3%
Tsinghua University Press
1 публикация, 0.3%
Open Access House of Science and Technology (OAHOST)
1 публикация, 0.3%
American Association for the Advancement of Science (AAAS)
1 публикация, 0.3%
Naksh Solutions
1 публикация, 0.3%
Afyon Kocatepe University
1 публикация, 0.3%
20
40
60
80
100
120
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
336
Поделиться
Цитировать
ГОСТ |
Цитировать
Zhang R. et al. Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives // Journal of Controlled Release. 2016. Vol. 240. pp. 489-503.
ГОСТ со всеми авторами (до 50) Скопировать
Zhang R., Wong H. L., Xue H. J., Eoh J. Y., Wu X. Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives // Journal of Controlled Release. 2016. Vol. 240. pp. 489-503.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/j.jconrel.2016.06.012
UR - http://linkinghub.elsevier.com/retrieve/pii/S0168365916303777
TI - Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
T2 - Journal of Controlled Release
AU - Zhang, Rui
AU - Wong, Ho Lun
AU - Xue, Hui Jun
AU - Eoh, June Young
AU - Wu, Xiao-Dong
PY - 2016
DA - 2016/10/01
PB - Elsevier
SP - 489-503
VL - 240
PMID - 27287891
SN - 0168-3659
SN - 1873-4995
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2016_Zhang,
author = {Rui Zhang and Ho Lun Wong and Hui Jun Xue and June Young Eoh and Xiao-Dong Wu},
title = {Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives},
journal = {Journal of Controlled Release},
year = {2016},
volume = {240},
publisher = {Elsevier},
month = {oct},
url = {http://linkinghub.elsevier.com/retrieve/pii/S0168365916303777},
pages = {489--503},
doi = {10.1016/j.jconrel.2016.06.012}
}